Effectiveness comparisons between tofacitinib, filgotinib and upadacitinib in ulcerative colitis: results from the JAKARTA real-world evidence multicenter study

被引：0

作者：

Buisson, A. ^{[1
]}

Treton, X. ^{[2
]}

Nachury, M. ^{[3
]}

Uzzan, M. ^{[4
]}

Bouguen, G. ^{[5
]}

Hamadidi, A. Banana ^{[1
]}

Amiot, A. ^{[6
]}

Serrero, M. ^{[7
]}

Fumery, M. ^{[8
]}

Caillo, L. ^{[9
]}

Hupe, M. ^{[10
]}

Pereira, B. ^{[1
]}

Altwegg, R. ^{[11
]}

机构：

[1] CHU Clermont Ferrand, IBD Unit, Clermont Ferrand, France

[2] Paris IBD Ctr, IBD Unit, Paris, France

[3] IBD Unit, CHRU Lille, Lille, France

[4] CHU Creteil, IBD Unit, Creteil, France

[5] CHU Rennes, IBD Unit, Rennes, France

[6] AP HP Kremlin Bicetre, IBD Unit, Paris, France

[7] AP HM, IB Unit, Marseille, France

[8] CHU Amiens, IBD Unit, Amiens, France

[9] CHU Nimes, IBD Unit, Nimes, France

[10] CHU Grenoble, IBD Unit, Grenoble, France

[11] CHU Montpellier, IBD Unit, Montpellier, France

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.0785

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0611

引用

页码：i1212 / i1212

页数：1

共 50 条

[41] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN ULCERATIVE COLITIS
Hong, Simon
Zullow, Samantha
Axelrad, Jordan
Chang, Shannon
Hudesman, David
GASTROENTEROLOGY, 2020, 158 (03) : S120 - S120
[42] Real-world comparison of effectiveness between tofacitinib and ustekinumab in patients with ulcerative colitis exposed to at least one anti-TNF agent: results from the TORUS study
Buisson, A.
Serrero, M.
Altwegg, R.
Guilmoteau, T.
Bouguen, G.
Nachury, M.
Amiot, A.
Vuitton, L.
Treton, X.
Caillo, L.
Pereira, B.
Fumery, M.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 707 - 707
[43] REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS EXPOSED TO AT LEAST ONE ANTI-TNF AGENT: RESULTS FROM THE TORUS STUDY
Buisson, Anthony
Serrero, Melanie
Altwegg, Romain
Guilmoteau, Thomas
Guillaume, Bouguen
Nachury, Maria
Amiot, Aurelien
Vuitton, Lucine
Treton, Xavier
Caillo, Ludovic
Pereira, Bruno
Fumery, Mathurin
GASTROENTEROLOGY, 2023, 164 (06) : S4 - S4
[44] Effectiveness of upadacitinib for induction of remission in moderate-to-severe ulcerative colitis: real-world clinical outcomes appear independent of prior tofacitinib exposure
Gonzalez, A. Elosua
Zabalza, L.
Vicuna, M.
Rubio, S.
Nantes, O.
Rodriguez, C.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1295 - i1295
[45] Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
Chaparro, Maria
Garre, Ana
Iborra, Marisa
Sierra-Ausin, Monica
Barreiro-de Acosta, Manuel
Fernandez-Clotet, Agnes
de Castro, Luisa
Bosca-Watts, Maia
Jose Casanova, Maria
Lopez-Garcia, Alicia
Lorente, Rufo
Rodriguez, Cristina
Carbajo, Ana Y.
Teresa Arroyo, Maria
Gutierrez, Ana
Hinojosa, Joaquin
Martinez-Perez, Teresa
Villoria, Albert
Bermejo, Fernando
Busquets, David
Camps, Blau
Canete, Fiorella
Mancenido, Noemi
Monfort, David
Navarro-Llavat, Merce
Lazaro Perez-Calle, Jose
Ramos, Laura
Rivero, Montserrat
Angueira, Teresa
Camo Monterde, Patricia
Carpio, Daniel
Garcia-de-la-Filia, Irene
Gonzalez-Munoza, Carlos
Hernandez, Luis
Huguet, Jose M.
Morales, Victor J.
Sicilia, Beatriz
Vega, Pablo
Vera, Isabel
Zabana, Yamile
Nos, Pilar
Suarez Alvarez, Patricia
Calvino-Suarez, Cristina
Ricart, Elena
Hernandez, Vicent
Minguez, Miguel
Marquez, Lucia
Hervias Cruz, Daniel
Rubio Iturria, Saioa
Barrio, Jesus
JOURNAL OF CROHNS & COLITIS, 2021, 15 (11): : 1846 - 1851
[46] One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy
Chiappetta, Michele Francesco
Viola, Anna
Mastronardi, Mauro
Turchini, Laura
Carparelli, Sonia
Orlando, Adele
Biscaglia, Giuseppe
Miranda, Agnese
Guida, Laura
Costantino, Giuseppe
Scaldaferri, Franco
Bossa, Fabrizio
Renna, Sara
Cappello, Maria
Alibrandi, Angela
Orlando, Ambrogio
Armuzzi, Alessandro
Fries, Walter
EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (11) : 1483 - 1489
[47] Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry
Chaparro, M.
Garre, A.
Iborra, M.
Sierra, M.
Barreiro-de Acosta, M.
Fernandez-Clotet, A.
de Castro, L.
Bosca-Watts, M.
Casanova, M. J.
Lopez-Garcia, A.
Lorente, R.
Rodriguez, C.
Carbajo, A. Y.
Arroyo, M. T.
Gutierrez, A.
Hinojosa, J.
Martinez-Perez, T.
Villoria, A.
Bermejo, F.
Busquets, D.
Camps, B.
Canete, F.
Mancenido, N.
Monfort, D.
Navarro-Llavat, M.
Perez-Calle, J. E.
Ramos, L.
Rivero, M.
Angueira, T.
Camo, P.
Carpio, D.
Garcia-de-la-Filia, I.
Gonzalez-Munoza, C.
Hernandez, L.
Huguet, J. M.
Morales, V. J.
Sicilia, B.
Vega, P.
Domenech, E.
Gisbert, J. P.
JOURNAL OF CROHNS & COLITIS, 2021, 15 : S465 - S466
[48] Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from Eneida Registry
Chaparro, M.
Garre, A.
Iborra, M.
Barreiro-de Acosta, M.
Casanova, M. J.
De Castro, L.
Fernandez-Clotet, A.
Hinojosa, J.
Bosca-Watts, M.
Busquets, D.
Lopez-Garcia, A.
Lorente, R.
Mancenido, N.
Martinez, T.
Monfort, D.
Perez-Calle, J. L.
Villoria, A.
Angueira, T.
Bermejo, F.
Carbajo, A. Y.
Carpio, D.
Gonzalez-Munoza, C.
Gomollon, F.
Huguet, J. M.
Rivero, M.
Iglesias-Flores, E.
Sierra, M.
Hernandez-Villalba, L.
Domenech, E.
Gisbert, J. P.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S394 - S395
[49] Effectiveness of tofacitinib in a real-world Israeli cohort of patients with moderate-severe ulcerative colitis
Biron, I. Avni
Shitrit, A. Bar-Gil
Koslowsky, B.
Kopylov, U.
Levartovsky, A.
Weisshof, R.
Aviv-Cohen, N.
Maharshak, N.
Hovel, D.
Naftali, T.
Goren, I.
Snir, I.
Ollech, J.
Banai, H.
Lena, B.
Dotan, I.
Yanai, H.
JOURNAL OF CROHNS & COLITIS, 2021, 15 : S498 - S499
[50] Upadacitinib is effective and safe for Ulcerative Colitis: prospective real-world experience
Friedberg, S.
Choi, D.
Hunold, T.
Choi, N. K.
Garcia, N. M.
Picker, E. A.
Cohen, N. A.
Cohen, R. D.
Dalal, S. R.
Pekow, J.
Sakuraba, A.
Cleveland, N. Krugliak
Rubin, D. T.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 707 - 708

← 1 2 3 4 5 →